These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1314177)
41. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo. de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400 [TBL] [Abstract][Full Text] [Related]
42. Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil. Silva LA; Reis-Cunha JL; Bartholomeu DC; Vítor RW PLoS One; 2017; 12(1):e0170689. PubMed ID: 28118394 [TBL] [Abstract][Full Text] [Related]
44. Effects of morphine addiction on the pathogenesis of murine toxoplasmosis. Chao CC; Sharp BM; Pomeroy C; Filice GA; Peterson PK Adv Exp Med Biol; 1991; 288():223-7. PubMed ID: 1950733 [No Abstract] [Full Text] [Related]
45. Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice. Murray HW; Teitelbaum R; Hariprashad J J Infect Dis; 1993 May; 167(5):1173-7. PubMed ID: 8486951 [TBL] [Abstract][Full Text] [Related]
46. Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii. Dubey JP; Yeary RA Can Vet J; 1977 Mar; 18(3):51-7. PubMed ID: 858118 [No Abstract] [Full Text] [Related]
47. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice. Nguyen BT; Stadtsbaeder S Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459 [TBL] [Abstract][Full Text] [Related]
48. Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis. Schöler N; Krause K; Kayser O; Müller RH; Borner K; Hahn H; Liesenfeld O Antimicrob Agents Chemother; 2001 Jun; 45(6):1771-9. PubMed ID: 11353624 [TBL] [Abstract][Full Text] [Related]
49. Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys. Schoondermark-van de Ven EM; Melchers WJ; Galama JM; Meuwissen JH; Eskes TK Eur J Obstet Gynecol Reprod Biol; 1997 Aug; 74(2):183-8. PubMed ID: 9306115 [TBL] [Abstract][Full Text] [Related]
50. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models. Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis. Reis TSA; Siqueira VDS; Ferreira SRR; Domann N; Rodrigues Júnior BA; Fleury ACC; Souza IMFNB; Cardoso LPV; Siqueira CS; Rezende HHA Rev Inst Med Trop Sao Paulo; 2024; 66():e61. PubMed ID: 39417497 [TBL] [Abstract][Full Text] [Related]
52. Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Derouin F; Caroff B; Chau F; Prokocimer P; Pocidalo JJ Antimicrob Agents Chemother; 1992 Dec; 36(12):2852-5. PubMed ID: 1482160 [TBL] [Abstract][Full Text] [Related]
53. [PCR in evaluating the effect of allicin and its combination with SMZco on murine toxoplamosis]. Shan LY; Yang XZ; Liu PM Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(4):203-6. PubMed ID: 14628365 [TBL] [Abstract][Full Text] [Related]
54. Toxoplasmosis in AIDS patients. Tuazon CU J Antimicrob Chemother; 1989 Jan; 23 Suppl A():77-82. PubMed ID: 2654118 [TBL] [Abstract][Full Text] [Related]
55. Increase of sulfadiazine effect against Toxoplasma gondii by using watermelon or cantaloupe seeds. Chinchilla M; Marín R; Catarinella G Rev Biol Trop; 1990 Nov; 38(2A):235-41. PubMed ID: 2101461 [TBL] [Abstract][Full Text] [Related]
56. [The effect of nifurtimox on intra- and extracellular development stages of Toxoplasma gonii]. Werner H; Gönnert R Arzneimittelforschung; 1974 May; 24(5):790-3. PubMed ID: 4408129 [No Abstract] [Full Text] [Related]
57. Chemotherapeutic efficacy of some agents against experimental toxoplasmosis in mice. Gupta SL; Gautam OP; Chhabra MB Indian J Med Res; 1981 Nov; 74():767-71. PubMed ID: 7341454 [No Abstract] [Full Text] [Related]
58. Antitoxoplasmic activity of sulfonamides with various radicals in experimental toxoplasmosis in mice. Brus R; Chrusciel TL; Steffen J; Szaflarski J Z Tropenmed Parasitol; 1971 Mar; 22(1):98-103. PubMed ID: 5555661 [No Abstract] [Full Text] [Related]
59. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii. Djurković-Djaković O; Milenković V; Nikolić A; Bobić B; Grujić J J Antimicrob Chemother; 2002 Dec; 50(6):981-7. PubMed ID: 12461021 [TBL] [Abstract][Full Text] [Related]
60. [Surface charged liposomes as drug carriers and in vivo tests of mice infected with toxoplasma]. Hou XP; Tao F; Yi YY; Wang WL Yao Xue Xue Bao; 1989 Jan; 24(1):53-7. PubMed ID: 2801125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]